Punjab, April 9 -- A New Hope for Patients with Advanced Gastric and Pancreatic CancersSHANGHAI, April 9, 2026 /PRNewswire/ - A groundbreaking new CAR-T cell therapy for advanced gastrointestinal cancers is expected to become available in China in the first half of 2026, marking a major step forward in cancer treatment. Jiahui International Cancer Center will be among the leading medical institutions offering access to this innovative therapy for eligible patients. The therapy, known as satri-cel (CT041), is the world's first CAR-T treatment specifically developed for solid tumors targeting Claudin18.2, a biomarker commonly found in gastric (stomach) and pancreatic cancers.A New Era in Cancer TreatmentCAR-T therapy is a highly personalized ...